clinical symptoms

The biomarker and clinical changes across the Alzheimer’s continuum study (BCAS): rationale, design, and baseline characteristics of the first 1,013 participants

Study Overview The BCAS study focuses on understanding the progression of Alzheimer’s disease through a comprehensive exploration of biomarker and

The biomarker and clinical changes across the Alzheimer’s continuum study (BCAS): rationale, design, and baseline characteristics of the first 1,013 participants Read Post »

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial

Study Overview The study aimed to evaluate the effectiveness and safety of mirikizumab, a monoclonal antibody targeting the IL-23 pathway,

Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial Read Post »

Scroll to Top